Skip to content

Powered by Doctor Evidence
  • GROWTH
  • Programs
    • DOC Congress
    • GROWTH Evidence
    • GROWTH Research
    • GROWTH Value
    • GROWTH Replicator
    • GROWTH Map
  • Technology
  • Knowledge
    • Commentaries
    • Publications
  • About
    • Team
    • Events
    • News
    • Contact
    • Members login

Tag: Real-world Evidence

Experimental trial design and routine data: A promising approach for real-world evidence

April 18, 2019 Heiner C. Bucher, MD, MPH

By Heiner C. Bucher, MD, MPH Director, Basel Institute for Clinical Epidemiology & Biostatistics University Hospital & University of Basel…

Continue Reading →

Posted in: Commentaries Author Filed under: Comparative Effectiveness Research, Digital Health, Patient Level Data, Real-world Evidence, Technology

Real-World Evidence to Increase Value in Health Care

July 20, 2018 McClellan et al.

By Mark McClellan, MD, PhD, Director of the Duke Margolis Center for Health Policy and the Robert J. Margolis, MD, Professor…

Continue Reading →

Posted in: Commentaries Author Filed under: Evidence-Based Health Policy, Healthcare Costs, Patient Level Data, Real-world Evidence

Understanding Global Health Statistics through Visual Presentations

October 19, 2017 Anna Rosling-Rönnlund

An Interview with Anna Rosling-Rönnlund, Gapminder Co-Founder and Vice President For this month’s commentary, GROWTH interviewed Anna Rosling-Rönnlund, Vice President…

Continue Reading →

Posted in: Commentaries Author Filed under: Epidemiology, Global Health, Meta-analysis, Real-world Evidence

Expanding Transparency in Health Estimation

June 21, 2017 Christopher J.L. Murray, MD, DPhil

By Christopher J. L. Murray, MD, DPhil Director, Institute for Health Metrics and Evaluation (IHME) Trust us. We’re experts. That…

Continue Reading →

Posted in: Commentaries Author Filed under: Epidemiology, Global Health, Healthcare Policy, Quality of Evidence, Real-world Evidence

Initiating a Discussion: Challenges and Opportunities for Use of Real World Data

March 15, 2015 Sandra Zelman Lewis

By Sandra Zelman Lewis, PhD, Chief Guidelines Officer, Doctor Evidence The importance of high quality double-blinded randomized controlled trials (RCTs) is…

Continue Reading →

Posted in: Commentaries Author Filed under: Digital Health, Evidence-Based Medicine, Patient Level Data, Real-world Evidence

Search…

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GROWTH: 1000 subscribers and counting!

reCAPTCHA is required.

Contact Us!

reCAPTCHA is required.

Recent Posts

  • Can AI Help Rescue the Healthcare Economic Crisis?
  • Thinking Differently About Evidence Development In the Age of Digital Health
  • Toward the Transformation of Healthcare Delivery: Digital Health Platforms

Recent Systematic Reviews

  • Screening for Lung Cancer: CHEST Guideline and Expert Panel Report
  • Effect of Dysphagia Screening Strategies on Clinical Outcomes After Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke
  • ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
  • Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
  • Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

SEARCH GROWTH

  • Privacy Policy
reCAPTCHA is required.
  • Twitter
  • Facebook
Copyright © 2025 — Lyrical WordPress theme by GoDaddy
Scroll Up